ARCHIVES

Interview with FDA’s Richard Pazdur

This article is from The Cancer Letter archive.

Vol. 35 No. 40 | October 30, 2009

Download PDF Visit The Full Archive

Related Articles

Barret’s Less of a Risk Factor For Cancer of the Esophagus

June 24, 2011

News Analysis: The Political Economy of Importation to Alleviate Cancer Drug Shortages

March 2, 2012

NCI Preparing RFA for Genetics Network; Patients Want Gene-Environment Studies

August 9, 1996

NTP Release Third Report On Carcinogens

January 13, 1984

NCI blocked groups from phase III Iressa studies.

April 30, 2004

Groups’ Growth, Impact Shown by Five-Year Data

March 3, 1978